Growth of UBS??

Finjerk's picture
Rank: Senior Monkey | 93

I have been reading up on UBS and looking at the recent league table rankings it has grown and is now back in the Top 6/7 for overall M&A dealflow. What are some views on UBS? Are people bullish on UBS growing in the coming years post Covid while other banks struggle with high default rates?

Comments (57)

  • Intern in IB-M&A
Jul 25, 2020

interested

Jul 25, 2020

bump

Array
Jul 25, 2020

UBS just released incredible earnings for ECM, DCM, and credit trading. Its S&T revenue in 2020 Q2 has been remarkable, and it ranks best in Europe for Equities and FX trading. True, its Investment Bank is smaller than most, with the focus being on Wealth Management; but it's faring incredibly well in Europe whereas others (Barclays, Deutsche) are really struggling.

    • 7
    • 2
Jul 27, 2020
  • Analyst 1 in IB - Ind
Jul 25, 2020

UBS restructured their IB last year and hired over 20 MDs this year alone. They cut down in coverage groups and really focused on industrials, tmt, and fig. Also, because they have a pretty good ECM group, they've been working a lot with SPACs.

    • 7
Jul 25, 2020

M&A deal flow is lumpy and a single good year is not really indicative of a wider trend

In revenue terms they are still smaller than DB, WF and even Jefferies

    • 2
Most Helpful
  • Intern in IB - Gen
Jul 25, 2020

Current SA and can say we have been winning a lot of mandates lately of all varieties. We have consistently been top 10 in global M&A this year. We are working on a ton of SPACs and even have a few high profile RX mandates. Yes, UBS has an RX team within LevFin. Small team of ~7 but one of the few BB who focus in RX. They take 1-2 SA. Coverage groups at the firm get to work on the RX deals as well.

We also have a new CEO coming in later this year. I am not sure on his intentions with IB but Sergio Ermotti (current CEO) wanted to downsize IB and focus on WM. Hopefully the new CEO (Ralph Hamers) will look to grow the investment bank

    • 11
Jul 25, 2020
Intern in IB - Gen:

Current SA and can say we have been winning a lot of mandates lately of all varieties. We have consistently been top 10 in global M&A this year. We are working on a ton of SPACs and even have a few high profile RX mandates. Yes, UBS has an RX team within LevFin. Small team of ~7 but one of the few BB who focus in RX. They take 1-2 SA. Coverage groups at the firm get to work on the RX deals as well.

We also have a new CEO coming in later this year. I am not sure on his intentions with IB but Sergio Ermotti (current CEO) wanted to downsize IB and focus on WM. Hopefully the new CEO (Ralph Hamers) will look to grow the investment bank

That's helpful! Working in the firm has it been super busy since you mentioned there are some high profile RX mandates going on. Also what are the MDs and seniors views on the bank going forward?

Jul 25, 2020

Friend at the firm is in a coverage group and he's super busy. As mentioned above, they work on w all products (including Rx). UBS decided to focus on Industrials, TMT, FIG, and Consumer so those groups (Industrials is top) are really busy. LevFin, ECM is really strong as well

Array

    • 1
  • Intern in IB - Gen
Jul 25, 2020

Yes, my group is getting crushed right now especially the analysts on the RX mandates. It's not only the RX mandates but a combination of M&A, ECM, DCM, LevFin deals.

Not sure exactly senior views on the bank but there's been a lot of MD hires lately. They like that the bank gives you the best of both worlds. The firm is small like a boutique but also provides the products and services like a BB. Senior bankers can provide strategic advice rather than leverage the bank's balance sheet like other BB do

    • 1
  • Analyst 1 in IB - Ind
Jul 28, 2020

Ok thanks for the insights, intern

    • 1
  • Intern in IB-M&A
Jul 25, 2020

Bump

  • Analyst 3+ in IB - Ind
Jul 25, 2020

bump

Jul 26, 2020

Let's just hope for everyone's sake they stay out of Fixed Income...

Jul 26, 2020

Heard the firm is building out an arena in NYC for the islanders, the name "UBS Arena" has a lot to be desired but it seems to show a strong commitment to their NYC franchise

    • 2
  • Intern in IB-M&A
Jul 26, 2020

"UBS Arena is a $1.5 billion multi-purpose arena under construction and development in Elmont, New York, next to the Belmont Park race track. The venue is projected to open for the 2021-22 NHL season."

    • 1
Jul 27, 2020

Curious why a Swiss investment bank with no commercial branch would sponsor an American hockey team, where's the value in that

Jul 27, 2020

Asset/Wealth Management, not IB - that's where their money come's from

Array
  • Analyst 1 in IB - Ind
Jul 28, 2020

We all realize that UBS isn't actually building the arena right? They bought the naming rights for publicity/advertising

    • 1
Funniest
Jul 28, 2020

I thought that's what UBS industrials is all about

    • 8
  • Analyst 2 in IB - Ind
Jul 26, 2020

UBS has the best ROE return among all investment banks! Thought UBS is ranked outside of top 20 in "completed" M&A deals now.

FYI interns..."Credit loss expenses rose to $268 million from $20 million for the same period last year" all because of the shitty levfin deals UBS underwrote

    • 7
  • Analyst 2 in IB-M&A
Jul 26, 2020

Not even at UBS but every fucking bank's credit loss provisions increased a shitton

  • Associate 3 in IB - Ind
Jul 26, 2020

I work at UBS in London. M&A league table driven by some jumbo deals ($10bn+) we were lucky to do this year. Also last year there was a massive cut in September, lots of deadweight loss combined with fresh blood. But let's see H2...

  • Analyst 2 in IB - Ind
Jul 26, 2020

how's the tmt and consumer team in uk? just curious

  • Associate 3 in IB - Ind
Jul 26, 2020

TMT is probably the best team here. They keep on landing big mandates, quality client relationships and recurring fees (tech and mostly telco, not media). Juniors there get a proper beating in terms of hours and intensity but they get solid experience.
Consumer not great. Weird culture, you know those teams who pull consistently 100+ hours per week and yet don't bring any fees? Consumer is one of them.

Jul 27, 2020

UBS took Bill Ackman public, largest SPAC IPO in Wall Street history. Definitely have landed some major deals this year

Array

    • 4
Jul 27, 2020

UBS was also an advisor to Hellman & Freemans' Multiplan sale to SPAC for $11bil

    • 1
  • Intern in IB-M&A
Jul 27, 2020

Since UBS has started to do well, how would exit look like again from the firm? Is there a possibility for a mega fund exit from a top group or usually UMM?

  • Intern in IB - Gen
Jul 27, 2020

You should know that the only banks where exits are "usually UMM" are GS / MS / Evercore type places

    • 3
    • 1
  • Intern in IB-M&A
Jul 27, 2020

What do UBS exits look like? Corp Dev? LMM? VC?

  • Intern in IB-M&A
Jul 28, 2020

Bump

  • Analyst 1 in IB - Ind
Jul 28, 2020

Am I late to the UBS circle jerk?

  • Analyst 1 in IB - Ind
Jul 28, 2020

I'm here

  • Intern in IB - Ind
Jul 29, 2020

I have heard that Industrials/TMT/Levfin are some of the top groups at UBS, but does anyone have any insight on the Healthcare or M&A groups and how they compare in terms of dealflow, exits, etc?

  • Intern in IB-M&A
Jul 29, 2020

interested

  • Analyst 3+ in IB - Ind
Jul 29, 2020

2 of the weaker groups in the bank. The coverage groups run a lot of the M&A processes themselves so M&A is not a great place to be (the hours are good though, I've seen those analysts leaving when I go down to get my Seamless many times). Healthcare is also not great, lost some important MDs and have struggled since.

Best groups are industrials, TMT, consumer, and levfin/sponsors.

Jul 29, 2020

Consumer is not strong in the US, their London consumer is solid though from what I hear. UBS has three primary coverage groups: TMT, Industrials, and FIG that are standalone and does their own modeling internally, each group has also been expanding with many MDs being poached. Every other coverage sector is put into one group and their modeling is handled by the product teams. UBS strategy is essentially to focus their resources into a few groups that has historically driven their IB revenue, and consumer isn't one of them.

    • 3
Jul 29, 2020
Analyst 3+ in IB - Ind:

2 of the weaker groups in the bank. The coverage groups run a lot of the M&A processes themselves so M&A is not a great place to be (the hours are good though, I've seen those analysts leaving when I go down to get my Seamless many times). Healthcare is also not great, lost some important MDs and have struggled since.

Best groups are industrials, TMT, consumer, and levfin/sponsors.

Pretty sure if the analyst is leaving when you are grabbing your pathetic seamless meal it would be a pretty GREAT place to be (probably gets the same pay as you anyways). Sign me up for that group!

  • Intern in IB-M&A
Jul 29, 2020
Comment
Jul 30, 2020
Aug 2, 2020